Key Insights:
- CVS Health is experiencing key changes in its financial leadership, positioning Brian Newman as the new CFO.
- Analysts provide a one-year average price target of $71.81, indicating a modest upside potential.
- GuruFocus estimates a significant potential upside of 26.23% based on the GF Value calculation.
CVS Health Corp (CVS, Financial) has announced pivotal changes in its financial department following Thomas Cowhey's resignation from the position of finance chief. In a strategic move to enhance the company's financial trajectory, Brian Newman has been appointed as the executive vice president and chief financial officer, commencing his role on April 21.
Wall Street's Analytical Outlook
Wall Street analysts have projected a one-year price target for CVS Health Corp (CVS, Financial) with an average estimate of $71.81. This represents a high estimate of $82.00 and a low of $48.01. With the current stock price at $69.51, this average target suggests a potential upside of 3.31%. Investors can find more detailed forecast information on the CVS Health Corp (CVS) Forecast page.
The consensus among 29 brokerage firms rates CVS Health Corp (CVS, Financial) at an average of 2.2, placing it in the "Outperform" category on the rating scale, which ranges from 1 (Strong Buy) to 5 (Sell).
GuruFocus Valuation Metrics
According to GuruFocus, the estimated GF Value for CVS Health Corp (CVS, Financial) over the next year is anticipated to be $87.74. This signifies a potential upside of 26.23% from the current trading price of $69.51. The GF Value is determined through historical trading multiples, past business growth, and future business performance projections. For more comprehensive data, please visit the CVS Health Corp (CVS) Summary page.
- CEO Buys, CFO Buys: Stocks that are bought by their CEO/CFOs.
- Insider Cluster Buys: Stocks that multiple company officers and directors have bought.
- Double Buys: Companies that both Gurus and Insiders are buying
- Triple Buys: Companies that both Gurus and Insiders are buying, and Company is buying back.
